Skip to content

PTSD: all studies

Page 93 of 211: studies 921 to 930 of 2,101, newest first. Back to the PTSD overview

Research

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Psychopharmacology July 1, 2026 Sarah Ann Smith, Haseeb Mohammad, Lik Hang N Lee et al.

Interest in psychedelic drugs has increased rapidly because of their potential therapeutic role in psychiatric disorders. Impairments in the sociocognitive skills needed to build and maintain social relationships are prominent features of many psychiatric and neurodevelopmental disorders. Emerging evidence suggests that compounds such as 3,4-methylenedioxymethamphetamine (MDMA), lysergic acid...

DOI: 10.1007/s00213-026-07110-y (opens in new tab) Full text (opens in new tab) Psychedelic drugs Scoping review Social cognition

Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia

Revista CienciaUANL July 1, 2026 Armando Ordaz‐hernández, M. Corona-Ramírez, Israel Jesús Orlando Guerrero

La psilocibina, presente en los “hongos mágicos”, y la 5-MeO-DMT, secretada por el sapo Incilius alvarius, fueron empleadas ancestralmente en rituales espirituales en México. Hoy, la ciencia las reconoce como terapias prometedoras contra depresión, ansiedad, estrés postraumático y adicciones resistentes a tratamientos convencionales. Actúan sobre receptores de serotonina y estimulan la...

DOI: 10.29105/cienciauanl29.138-5 (opens in new tab) Addiction Mental health Clinical practice Psychotherapist

A review of the therapeutic and neuroprotective properties of ketamine

Medical Science of Ukraine June 30, 2026 Viacheslav Zaika, Yan Tytarenko

Relevance. Depression is one of the leading causes of disability worldwide, and a significant proportion of patients suffer from treatment-resistant forms of the disorder. An innovative approach involves the use of ketamine and esketamine, which are capable of inducing a “window of neuroplasticity” – a period of enhanced synaptogenesis and the formation of new neural connections. Theoretically,...

Evaluating the Impact of Transcendental Meditation on Trauma Symptoms, Depression, Anxiety, and Sleep Problems Among Israeli Civilians Post-October 7, 2023: A Pilot Study.

Journal of Clinical Psychology June 29, 2026 Ofra Walter, Sanford Nidich, Kimia Shahrokhi

The mass evacuation of Israeli residents from conflict zones after the events of October 7, 2023, coupled with ongoing security threats, has taken a substantial psychological toll, with many individuals exhibiting symptoms of post-traumatic stress disorder (PTSD), anxiety, and sleep problems. This pilot study examined the feasibility and preliminary within-group changes associated with...

DOI: 10.1002/jclp.70172 (opens in new tab) Full text (opens in new tab) Anxiety Israeli–palestinian conflict Civilian evacuations Displaced populations +5

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of Psychopharmacology June 28, 2026 Yingjie Du, Xiangting Zhao, Yishan Yao et al.

BACKGROUND: Posttraumatic stress disorder (PTSD) and major depressive disorder are often comorbid in humans. Psilocybin reportedly has beneficial therapeutic effects on depression, possibly by promoting neuroplasticity. PTSD is associated with the dysregulation of neuroplasticity in the hippocampus and medial prefrontal cortex (mPFC). We hypothesized that psilocybin might reduce fear memory by...

Treatment of phobias and mental disorders with the help of hypnosis and meditation

Revista de Neuro-Psiquiatría June 22, 2026 Liana Spytska

This review explores the therapeutic potential of hypnosis and meditation in managing phobias and mental disorders, particularly as non-pharmacological adjuncts in psychotherapeutic practice. The increasing global incidence of mental health conditions, coupled with interest in integrative treatment approaches, underscores the relevance of this study. A systematic review of peer-reviewed...

NMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 20, 2026 Aline Freyssin, Reina Benabou, Hanna Zoe Müller et al.

Despite recent advances in neuropsychiatry, translational development for many targets remains challenging, particularly when receptors exist as families with complex subunit-dependent pharmacology and safety concerns. This is the case for NMDA receptor (NMDAR) antagonists. R,S-ketamine illustrates this issue: although it produces rapid antidepressant effects in the clinic, its use is limited...

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation

PLoS One June 18, 2026 Elisa Liberati, Hv Curran, Peter Fonagy et al.

INTRODUCTION: Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a potentially transformative intervention for post-traumatic stress disorder (PTSD). Despite encouraging Phase III trial results, the psychological mechanisms underpinning MDMA's therapeutic effects remain insufficiently understood. Existing research on MDMA has emphasised neurobiological processes but has...

DOI: 10.1371/journal.pone.0350728 (opens in new tab) MDMA Grounded theory Interpretative phenomenological analysis Thematic analysis +14

Psychedelics, the media portrayal and large-language model evaluations

BJPsych Open June 18, 2026 Catherine L. Clelland

Psychedelics were used for centuries in healing and spiritual rituals, long before the mid-20th century when they became subjects of biomedical research. Although initial trials generated optimism, these were quickly overshadowed by sensationalist media coverage and political backlash. Following decades of inactivity, research on compounds including 3,4-methylenedioxymethamphetamine (MDMA) has...

DOI: 10.1192/bjo.2026.12025 (opens in new tab) Full text (opens in new tab) Sensationalism Politics Field mathematics Headline +10

Design and effectiveness evaluation of a web-based microplatform for mindfulness intervention for organ donor family members.

Internet Interventions June 17, 2026 Yuanxin Cao, Sitong Huang, Shufeng Kong et al.

Background: Organ transplantation technology provides life-saving treatment for patients with end-stage organ failure. However, family members of donors face psychological harm due to the urgent decision-making process regarding organ donation and the associated stigmatization, highlighting an urgent need for mental health support. Methods: This study used the User Version of the Mobile...

DOI: 10.1016/j.invent.2026.100967 (opens in new tab) Full text (opens in new tab) Mindfulness Mental health Digital intervention Web-based microplatform